SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-074239
Filing Date
2016-01-05
Accepted
2016-01-05 21:00:50
Documents
1
Period of Report
2016-01-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v428377_4.html 4  
1 OWNERSHIP DOCUMENT v428377_4.xml 4 9443
  Complete submission text file 0001144204-16-074239.txt   10855
Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES STREET NEW YORK NY 10013
Business Address
Duncan Barbara Gayle (Reporting) CIK: 0001353128 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 161325175